Substance Use Disorder Clinical Trial
Official title:
Preventing Persistent Post-Surgical Pain and Opioid Use In At-Risk Veterans: Effect of ACT
A large number of veterans suffer from distress-based conditions, such as anxiety and
depression, putting them at high risk of experiencing persistent pain and prolonged opioid
use following surgery. These connections are based on strong and consistent evidence from the
literature and our preliminary data. The proposed study adds a 1-day workshop of Acceptance
and Commitment Therapy (ACT), followed by an individual "booster" session, to treatment as
usual (TAU) to reduce veterans' risk of persistent pain and prolonged opioid use following
surgery. ACT has been shown to be effective in reducing chronic pain, anxiety and depression.
This pilot study will establish the feasibility and preliminary efficacy of incorporating ACT
into treatment as usual (TAU) to preoperatively target distress-based risk factors. Aim 1 is
to establish the feasibility of successfully delivering ACT to at-risk veterans before and
after surgery. Aim 2 is to test the preliminary efficacy of ACT on the length and/or amount
of pain and opioid use after surgery. Veterans who are anxious or depressed before surgery
will be randomly assigned to receive ACT plus TAU or TAU. Outcomes between the two groups
will be compared. Aim 3 is to see if PROMIS modules, developed by the National Institute of
Health, are useful for assessing pain and other symptoms in veterans. Findings from this
study will be used to inform the design and implementation of a larger, well controlled,
randomized clinical trial that will evaluate the efficacy of ACT plus TAU for at-risk
veterans.
This study will take place at the Iowa City VA Health Care System (VAMC). Veterans scheduled
for orthopedic or open abdominal surgery in 1 to 3 months who score high for anxiety or
depression will be randomly assigned to attend a 1-day ACT workshop preoperatively, with an
individualize "booster" session postoperatively, or to have TAU. Veterans who receive ACT and
trainers who provide the treatment will be interviewed to identify barriers and facilitators
to providing ACT to at-risk veterans before and after surgery. Other primarily outcomes are
pain and opioid use after surgery. Factors that may affect these outcomes will also be
measured, including anxiety, depression, substance use disorder, post-traumatic stress
disorder, and use of other pain meds.
The investigators expect to gain important knowledge about ways to best include ACT as part
of routine care for veterans requiring surgery and about the preliminary efficacy of ACT for
the prevention of persistent pain and prolonged opioid use following surgery.
A large number of veterans suffer from distress-based conditions, such as anxiety and
depression, putting them at risk of experiencing persistent pain and prolonged opioid use
following surgery. Preventing these problems (our long term goal) for the thousands of
veterans who undergo surgery each year can have a dramatic impact on quality of life and
productivity, including positive effects on mood, daily activities, sleep, cognitive
functions, social life and decreased risk of suicide (1, 2). In addition to these benefits
for individual veterans, prevention of these problems can significantly reduce the estimated
billions of dollars associated with veterans' utilization of the healthcare system as well as
costs associated with lost work productivity, including unemployment and disability benefits
(3).
Building on strong and consistent evidence showing that high anxiety and depression put
veterans at risk for persistent pain and prolonged opioid use following surgery (4, 5), this
proposal tests the feasibility and preliminary efficacy of implementing a 1-day training
session with Acceptance and Commitment Therapy (ACT) in veterans identified to be at-risk
prior to surgery. ACT has been shown to significantly lower distress and disability in
patients with chronic pain (6-8) and is particularly valuable intervention for the 80% of
veterans who experience some level of psychological distress prior to surgery (9) and the 50%
of veterans who report they experience pain on a regular basis (10, 11). Current practice
does not include psychological interventions specifically aimed at addressing distress-based
conditions prior to surgery. This study is a necessary first step in evaluating the efficacy
of this novel intervention during a critical juncture in care to benefit veterans and prevent
the devastating consequences of persistent pain and prolonged opioid use following surgery.
This project is based on our interdisciplinary team's research on psychological factors
predicting persistent pain after total knee replacement (12) and the effect of ACT on
depression and pain in depressed migraine sufferers (13). The design of this 1-day workshop
was developed based on feedback given by patients who received ACT during co-I Dindo's
preliminary study. The rationale for this research is that, once we determine the feasibility
and preliminary efficacy of incorporating this 1-day workshop into treatment as usual (TAU)
to preoperatively target distress-based risk conditions, findings from this study will be
used to inform the design and implementation of a larger, well controlled, randomized
clinical trial that will evaluate the efficacy of ACT plus TAU (ACT + TAU) for at-risk
veterans. The following specific aims will be achieved:
- Aim #1: The primary aim of this pilot study is to determine the feasibility of
successfully delivering a 1-day ACT intervention with at-risk veterans prior to surgery
and an individualized "booster" session after surgery. The following aspects of the
intervention will be assessed: 1) the number of at-risk veterans who are willing and
able to receive the ACT workshops and individual "booster" sessions; 2) veteran
identification of barriers and facilitators to receiving the ACT intervention and
utilizing the skills taught; 3) trainer identification of barriers and facilitators to
providing the ACT intervention with at-risk veterans before and after surgery; and 4)
veteran and trainer suggestions about ways to improve the intervention. These aspects
will be assessed primarily through guided open-ended interviews after the ACT workshop
and 3 months postoperatively.
- Aim #2: To determine if a 1-day preoperative ACT workshop with an individualized
"booster" session postoperatively reduces the length and/or amount of pain and opioid
use following surgery when compared to treatment as usual (TAU). Participants will be
randomized to ACT + TAU or TAU and record pain and opioid use daily after surgery.
- Aim #3: A secondary, exploratory aim is to determine the usability and utility of the
Patient Reported Outcomes Measurement Information System (PROMIS) modules for assessing
pain and associated symptoms in veterans. We will compare modules to the Brief Pain
Inventory (Pain Interference), the State/Trait Anxiety Inventory (Anxiety), and the
Patient Health Questionnaire (PHQ)-9 (Depression).
This project has the potential to infuse what is known about effective treatment of chronic
pain into the acute care environment to benefit veterans and improve surgical outcomes. It
incorporates an interdisciplinary approach to the care of veterans that attends to the
psychology of pain.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03042832 -
Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention
|
N/A | |
Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
Completed |
NCT01693978 -
Contingency Outcomes in Prolonged Exposure
|
N/A | |
Withdrawn |
NCT05448118 -
Virtual MOUD Treatment- Virtual POC Toxicology
|
N/A | |
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
Recruiting |
NCT01979133 -
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
|
Phase 3 | |
Completed |
NCT02308878 -
Mobile Health Cognitive Stimulation in Heroin Users
|
N/A | |
Completed |
NCT01189552 -
Depression Treatment for Low Income Substance Users
|
N/A | |
Completed |
NCT01280916 -
Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment
|
Phase 1 | |
Completed |
NCT02964897 -
Improving Linkage to Health and Other Services for Veterans Leaving Incarceration
|
N/A | |
Not yet recruiting |
NCT06315660 -
VR Based Therapy to Treat Anxiety in Dual Diagnosis
|
N/A | |
Completed |
NCT02579317 -
Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
|
N/A | |
Completed |
NCT01003834 -
Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care
|
N/A | |
Completed |
NCT03538860 -
Validation of an Automated Online Language Interpreting Tool - Phase Two.
|
N/A | |
Completed |
NCT02656745 -
Clinical Trial of Smoking Cessation Mobile Phone Program
|
N/A | |
Active, not recruiting |
NCT03331354 -
Assessing the Effect of Distance Learning Vocational Rehabilitation on Employment Outcomes of Veterans With Psychiatric Illness and Histories of Legal Convictions
|
N/A | |
Completed |
NCT02110693 -
The Tobacco, Alcohol, Prescription Medication and Other Substances Tool
|
N/A | |
Not yet recruiting |
NCT06432985 -
Smoking Cessation CM for Veterans With or at Risk for Cancer
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05415891 -
The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta
|
N/A |